Long-term survival after multidisciplinary treatments for HER2-positive advanced gastric cancer with multiple liver and lung metastases

BACKGROUND: Trastuzumab-based chemotherapy is a standard treatment regimen for human epithelial growth factor 2 (HER2)-positive gastric cancer. This is a case of a patient who has survived 12 years after being diagnosed with advanced gastric cancer with multiple liver and lung metastases. CASE PRESE...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshioka, Satoshi, Takahashi, Naoto, Fujisaki, Muneharu, Takeshita, Kenji, Takano, Yuta, Yano, Fumiaki, Toya, Naoki, Eto, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406778/
https://www.ncbi.nlm.nih.gov/pubmed/37548808
http://dx.doi.org/10.1186/s40792-023-01714-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406778/
https://www.ncbi.nlm.nih.gov/pubmed/37548808
http://dx.doi.org/10.1186/s40792-023-01714-8

Ejemplares similares